The Vall d´Hebron Institute of Oncology (VHIO) Seeks a "Laboratory Technician at Tumor Biomarkers Team" Reference: 2024-069-01 Application deadline: 06/12/2024 Number of vacancies: 1 Job description: We seek a Laboratory Technician to join the Tumor Biomarkers Team, led by Josep Villanueva, in the Proteomics Group of the Vall d´Hebron Institute of Oncology (VHIO).
The main goal of the laboratory is to characterize the mechanisms adopted by cancer cells to communicate amongst themselves as well as with their microenvironment during tumorigenesis and exploit these data to advance biomarker and drug target discovery.
We are seeking an organized, motivated and team-oriented individual.
The successful candidate will join the scientific team supporting the development of different projects, but also will coordinate and assist lab managing duties.
Main tasks: Perform organizational and logistical tasks for the laboratory, including ordering products, organizing biological samples, among others.
Assist the research team in executing research experiments related to the different ongoing research projects in our laboratory.
Requirements: Applicants must have a BSc and at least two years of experience in molecular and cellular biology techniques performed in a research laboratory.
Experience in Cell culture techniques, Western Blot and Immunofluorescence microscopy is required.
Experience in animal experimentation will be favorably considered.
The candidate is expected to be able to communicate well in English.
Additional information: What we offer: The opportunity to develop your professional career in a competitive environment.
To be part of a center that is in constant development, seeking excellence in research and collaborating with leading teams.
We offer and promote a diverse and inclusive environment, and welcome all people equally, regardless of age, disability, gender, nationality, race, religion or sexual orientation.
VHIO has been awarded the HR Excellence in Research Badge that identifies the institutions and organisations as providers and supporters of a stimulating and favourable working environment for Research.
We care about our environment and understand the importance of sustainability.
We have the GreenVhio program, which you can be a part of.
Working conditions: Permanent contract.
Fresh fruit every Tuesday.
Salary according to qualifications and experience following VHIO pay scales.
Flexible remuneration program (includes restaurant vouchers/cards, transport, medical insurance, and "baby daycare" voucher).
Flexible working hours and measures to balance work, family, and personal life, and promote gender equality, as established in the VHIO collective agreement.
23 days of holidays and 5 personal days.
Fully subsidized Catalan, Spanish, or English courses.
Application: Potential candidates should submit a curriculum vitae, letter of intent, to ****** including the reference "Ref.
2024-069-01" in the subject line of your email.
About VHIO: Under the leadership of Josep Tabernero, the Vall d'Hebron Institute of Oncology (VHIO), has established itself as a comprehensive cancer center of proven excellence internationally.
It is also thanks to VHIO's optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.
Located within the Vall d'Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d'Hebron physician-scientists.
Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge.
This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.
VHIO's pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread, and more effectively treating even the most undruggable tumor types.
VHIO's translation toward precision oncology: https://www.vhio.net #J-18808-Ljbffr